MA52629A - Agents inhibiteurs de la tyrosine kinase de bruton - Google Patents
Agents inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA52629A MA52629A MA052629A MA52629A MA52629A MA 52629 A MA52629 A MA 52629A MA 052629 A MA052629 A MA 052629A MA 52629 A MA52629 A MA 52629A MA 52629 A MA52629 A MA 52629A
- Authority
- MA
- Morocco
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- bruton tyrosine
- bruton
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862671053P | 2018-05-14 | 2018-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52629A true MA52629A (fr) | 2021-03-24 |
Family
ID=67002348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052629A MA52629A (fr) | 2018-05-14 | 2019-05-13 | Agents inhibiteurs de la tyrosine kinase de bruton |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10899753B2 (fr) |
| EP (1) | EP3793994B1 (fr) |
| JP (1) | JP7359782B2 (fr) |
| AR (1) | AR115085A1 (fr) |
| ES (1) | ES2968222T3 (fr) |
| MA (1) | MA52629A (fr) |
| TW (1) | TW202016097A (fr) |
| UY (1) | UY38233A (fr) |
| WO (1) | WO2019222101A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11820760B2 (en) | 2018-10-15 | 2023-11-21 | Biogen Ma Inc. | Crystalline polymorphs of Bruton's tyrosine kinase inhibitors |
| CN110627775A (zh) * | 2019-10-24 | 2019-12-31 | 嘉兴特科罗生物科技有限公司 | 一种小分子化合物 |
| WO2021133894A1 (fr) * | 2019-12-23 | 2021-07-01 | Biogen Ma Inc. | Inhibiteurs de la btk |
| CN112062691B (zh) * | 2020-06-18 | 2022-12-09 | 中国农业科学院油料作物研究所 | 一种柠檬醛苯丁酸肟酯类化合物及其合成方法和应用 |
| WO2022212893A1 (fr) | 2021-04-02 | 2022-10-06 | Biogen Ma Inc. | Méthodes de traitement combiné de la sclérose en plaques |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| KR20140131955A (ko) | 2012-03-09 | 2014-11-14 | 카나 바이오사이언스 인코포레이션 | 신규 트리아진 유도체 |
| CA2932608C (fr) * | 2013-12-11 | 2023-02-14 | Biogen Ma Inc. | Composes biaryliques utiles pour le traitement de maladies humaines en oncologie, en neurologie et en immunologie |
| ES2713196T3 (es) | 2013-12-11 | 2019-05-20 | Biogen Ma Inc | Compuestos de biarilo útiles para el tratamiento de enfermedades humanas en oncología, neurología e inmunología |
| US20180282310A1 (en) | 2015-06-10 | 2018-10-04 | Biogen Ma Inc. | Forms and compositions of biaryl inhibitors of bruton's tyrosine kinase |
-
2019
- 2019-05-13 UY UY0001038233A patent/UY38233A/es not_active Application Discontinuation
- 2019-05-13 MA MA052629A patent/MA52629A/fr unknown
- 2019-05-13 AR ARP190101270A patent/AR115085A1/es unknown
- 2019-05-13 JP JP2020564219A patent/JP7359782B2/ja active Active
- 2019-05-13 ES ES19732766T patent/ES2968222T3/es active Active
- 2019-05-13 US US16/410,725 patent/US10899753B2/en active Active
- 2019-05-13 EP EP19732766.1A patent/EP3793994B1/fr active Active
- 2019-05-13 TW TW108116422A patent/TW202016097A/zh unknown
- 2019-05-13 WO PCT/US2019/032018 patent/WO2019222101A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021523206A (ja) | 2021-09-02 |
| EP3793994A1 (fr) | 2021-03-24 |
| TW202016097A (zh) | 2020-05-01 |
| EP3793994B1 (fr) | 2023-08-23 |
| AR115085A1 (es) | 2020-11-25 |
| ES2968222T3 (es) | 2024-05-08 |
| US10899753B2 (en) | 2021-01-26 |
| US20190382394A1 (en) | 2019-12-19 |
| UY38233A (es) | 2019-12-31 |
| WO2019222101A1 (fr) | 2019-11-21 |
| JP7359782B2 (ja) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53921A (fr) | Inhibiteurs de protéine tyrosine phosphatase | |
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA42623A (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| MA55511A (fr) | Inhibiteurs de protéine tyrosine phosphatase | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| MA43162A (fr) | Inhibiteurs de type imidazopyrazine de tyrosine kinase de bruton | |
| MA54327A (fr) | Inhibiteurs de kras g12c | |
| DK3710439T3 (da) | Kras g12c-hæmmere | |
| MA42242A (fr) | Inhibiteurs de la tyrosine kinase | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| DK3303334T3 (da) | Tyrosinkinasehæmmere | |
| MA51616A (fr) | Inhibiteurs d'adn-pk | |
| ZA201805439B (en) | Bruton's tyrosine kinase inhibitors | |
| DK3265084T3 (da) | Farmaceutiske formuleringer af Bruton's tyrosinkinase-hæmmer | |
| MA52629A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton | |
| EP3414234A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| BR112017020743A2 (pt) | cocristais de um inibidor da tirosina cinase de bruton. | |
| ZA201906887B (en) | Bruton's tyrosine kinase inhibitors | |
| MA41827A (fr) | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton | |
| DK3609886T3 (da) | Benzoazepinanaloger som inhiberingsmidler for bruton-tyrosinkinase | |
| CL2021000426A1 (es) | Inhibidores de la interacción proteína-proteína keap1-nrf2. | |
| ZA201903694B (en) | Inhibitors of bruton's tyrosine kinase | |
| MA51619A (fr) | Inhibiteurs de la protéine kinase dépendante de l'adn | |
| MA42510A (fr) | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton |